The FDA expanded the approval of trastuzumab deruxtecan for treatment of breast cancer.The new indication applies to use of ...

Triple-negative breast cancer (TNBC) has long been one of the most difficult forms of breast cancer to treat. Unlike other breast cancer subtypes, TNBC lacks ...

A new review was published in Oncotarget's Volume 16 on January 20, 2025, titled "Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms." ...

A research team at the Medical University of Vienna led by Maria Sibilia has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone ...

Several new treatment options for patients with breast cancer have emerged over the last few years, including more oral ...

People with mutations in the genes BRCA1, BRCA2 and PALB-2 have a high risk of developing breast cancer. If women have these genes, their options for treatment often include surgical removal of both ...

If your oncologist worries that your body is not strong enough to withstand chemotherapy, they will likely recommend other treatment options. Factors to consider ... most women diagnosed with ...

The University of Iowa study is analyzing the period between breast cancer diagnosis and treatment, when many patients feel ...

A Peter Mac-led international clinical trial has shown adding an immunotherapy drug to the chemotherapy that patients receive ...

A new study led by researchers at Moffitt Cancer Center shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed.